semaglutide for heart failure VisualAbstract: improves symptoms in patients with In patients with heart failure

Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial

Woeller, D.O., hosted by Lindsay Goddard, RD deep dives into the history and science of the Organic Acids Test

Schedule your appointment now and let the experts guide you on the right treatment plan

Patients carrying high-sensitivity variants benefit from lower doses, slower titration schedules, or dual-compound formulations like GLP-Squared Injection ($289/month), which balances semaglutide with tirzepatide to spread receptor activation across multiple pathways

Gut microbiota and cardiovascular disease: Symbiosis versus dysbiosis

Formulation choice affects dosing frequency and user experience